Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.5.5 entry is added to the history, superseding the previous Revision: v3.5.4. This reflects a site-wide update to the page rendering or tooling rather than a change to the study data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision labeled v3.5.4 has been added to the page's history, replacing the previous v3.5.3 entry and updating the version shown in the footer.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s footer now shows a new ClinicalTrials.gov site revision (v3.5.3 rather than v3.5.2), reflecting an update to the platform version rather than changes to the clinical trial record itself.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision history updated to include a new revision v3.5.0 and remove the older v3.4.3.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded revision v3.4.3 to the record history and removed revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.